Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.003
Buy
RSI(14)
49.893
Neutral
STOCH(KDJ)(9,3,3)
70.268
Neutral
ATR(14)
0.112
High Vlolatility
CCI(14)
-44.236
Neutral
Williams %R
33.333
Buy
TRIX(12,20)
0.095
Sell
StochRSI(14)
35.420
Sell
Search
Molecular Partners AG
MOLNAdd to Watchlist
4.020USD
+0.050+1.26%
Close 07-23 16:00（ET）Quotes delayed by 15 min
150.79MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+1.26%
5 Days
-1.95%
1 Month
+5.51%
6 Months
-1.71%
Year to Date
-7.77%
1 Year
+3.21%
Key Figures
3.980Open
3.980High
24.00Volume
LossP/E TTM
33.94P/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
3.970Prev. Close
3.980Low
59.00Turnover
LossP/E Static
1.72P/B
0.00%Div Yield TTM
-50.73%ROA
5.36052wk High
0.02Volume Ratio
-54.04MNet Profit
37.51MShares
-1.9448EPS TTM
1.07Beta
-59.01%ROE
3.41052wk Low
0.00%Amplitude
100.00%Gross Margin
150.79MMarket Cap
1.44Reward/Risk
3.12%Risk Rate
TradingKey Stock Score of Molecular Partners AG
Currency: USD Updated: 2026-07-23Key Insights
Molecular Partners AG's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 153 out of 386 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 13.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Molecular Partners AG's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Molecular Partners AG Highlights
StrengthsRisks
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Fairly Valued
The company’s latest PE is -2.05, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.59M shares, decreasing 0.34% quarter-over-quarter.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
13.000
Target Price
+216.30%
Upside Space
Molecular Partners AG News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
5
analysts
Buy
Current Rating
13.000
Target Price
+216.30%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
495
Total
6
Median
7
Average
Company name
Ratings
Analysts
Molecular Partners AG
MOLN
5
Beigene Ltd
ONC
28
argenx SE
ARGX
27
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
3.992
Buy
MA10
4.000
Buy
MA20
3.984
Buy
MA50
3.946
Buy
MA100
4.164
Sell
MA200
4.196
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Molecular Partners AG Info
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Ticker SymbolMOLN
CompanyMolecular Partners AG
CEOAmstutz (Patrick)
Websitehttps://www.molecularpartners.com/
Shareholders
Related Instruments
-0.24%
0.00%
0.00%
0.00%
0.00%
-1.09%
0.00%
+0.77%
0.00%
-1.20%
+0.02%
0.00%
0.00%
-1.66%
0.00%
0.00%
0.00%
+0.42%
+1.31%
0.00%Popular Instruments
FAQs
What is the current price of Molecular Partners AG (MOLN)?
The current price of Molecular Partners AG (MOLN) is 4.02.
What is the symbol of Molecular Partners AG?
The ticker symbol of Molecular Partners AG is MOLN.
What is the 52-week high of Molecular Partners AG?
The 52-week high of Molecular Partners AG is 5.36.
What is the 52-week low of Molecular Partners AG?
The 52-week low of Molecular Partners AG is 3.41.
What is the market capitalization of Molecular Partners AG?
The market capitalization of Molecular Partners AG is 150.79M.
Is Molecular Partners AG (MOLN) currently rated as Buy, Hold, or Sell?
According to analysts, Molecular Partners AG (MOLN) has an overall rating of Buy, with a price target of 13.00.
What is the Earnings Per Share (EPS TTM) of Molecular Partners AG (MOLN)?
The Earnings Per Share (EPS TTM) of Molecular Partners AG (MOLN) is -2.09.